D&O Ongoing Disclosure Notice – Bevan John Walsh

To NZX Limited; and
Name of listed issuer:
Date this disclosure made:
Date of last disclosure:

Third Age Health Services Limited
1-Mar-22
11-Feb-21

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:

1

Class of quoted financial products:
Nature of relevant interest:

Not applicable
Not applicable



Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013


Director or senior manager giving disclosure

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)












Details of transactions requiring disclosure-

















Summary of other relevant interests after acquisition or disposal:

For that relevant interest,-

Full name(s):
Name of listed issuer:
Name of related body corporate (if applicable):
Position held in listed issuer:


Bevan John Walsh
Third Age Health Services Limited
Not applicable
Director

Number held in class:
Current registered holder(s):

Not applicable
Not applicable

Class of affected quoted financial products:

Nature of the affected relevant interest(s):

For that relevant interest-
Number held in class before acquisition or disposal:
Number held in class after acquisition or disposal:
Current registered holder(s):
Registered holder(s) once transfers are registered:

Ordinary shares
Registered holder and benefical
owner

4,332,731
4,329,617
Bevan John Walsh
Unknown

Date of transaction:
Nature of transaction:
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Number of financial products to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Date of the prior written clearance (if any):

25-Feb-22
On market sale of ordinary shares
Unknown


$8,345.52
3,114

No

Not applicable
Not applicable

Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:



1-Mar-22



For a derivative relevant interest,-
Type of derivative:

Not applicable